4F-PCC bests frozen plasma as factor replacement for cardiac surgery bleeds
For physicians requiring coagulation factor replacement to control bleeding after CPB during surgery, 4F-PCC provides superior haemostatic efficacy over frozen plasma, along with some safety advantages, as shown in the FARES-II trial presented at ACC.25